Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prosthetic valve endocarditis is a catastrophic complication of cardiac valve replacement, associated with high mortality rates. Medical treatment is effective in a few instances of endocarditis involving the leaflets alone in bioprostheses. However, accurate diagnosis, better myocardial protection, and improved surgical strategies have led to better survival in patients undergoing surgery after failed conservative therapy. This comprehensive review addresses various issues involved in the management of this complication.

Original publication




Journal article


Ann Thorac Surg

Publication Date





1151 - 1158


Anti-Bacterial Agents, Bioprosthesis, Cardiac Surgical Procedures, Echocardiography, Transesophageal, Endocarditis, Equipment Design, Heart Valve Prosthesis, Humans, Prognosis, Treatment Outcome